Charles Gaber

3.1k citations
41 papers · 540 indexed · h-index 13
Topics
Esophageal Cancer Research and Treatment (7 papers)Esophageal and GI Pathology (7 papers)Eosinophilic Esophagitis (6 papers)

In The Last Decade

Charles Gaber

34 papers receiving 520 citations

Peers

Charles Gaber
Comparison fields: 5 of 80
  • Surgery 216
  • Pulmonary and Respiratory Medicine 193
  • Oncology 160
  • Cancer Research 60
  • Gastroenterology 53
Replace Jin Lee with:
Jin Lee South Korea
G. M. Kacl Switzerland
Emad Rahmani United States
Marco Bononi Italy
Francesco De Leonardis Italy
Suman Kochhar India
Konstantina Kontogianni Germany
Neil Parikh United States
Francesco Saverio Lucido Italy
Sara A. Mansfield United States
Charles Gaber relative to Jin Lee South Korea Jin Lee's profile →
Citations per field
00.5×2.7×
Jin Lee · 1×
Citations per year

Countries citing papers authored by Charles Gaber

Since Specialization
Citations

This map shows the geographic impact of Charles Gaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Gaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Gaber more than expected).

Fields of papers citing papers by Charles Gaber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Gaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Gaber. The network helps show where Charles Gaber may publish in the future.

Co-authorship network of co-authors of Charles Gaber

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Gaber. A scholar is included among the top collaborators of Charles Gaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Gaber. Charles Gaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 0
5 0
6 1
7 4
8 0
9 4
10 3
11 3
12 1
13 12
14 35
15 10
16 20
17 28
18 30
19 48
20 73

About Charles Gaber

Charles Gaber is a scholar working on Family Practice, Geriatrics and Gerontology and Gastroenterology, having authored 41 papers that have together received 540 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (7 papers), Esophageal and GI Pathology (7 papers) and Eosinophilic Esophagitis (6 papers). The work is most often cited by research in Gastroenterology (53 citations), Equine (11 citations) and Pulmonary and Respiratory Medicine (193 citations). Charles Gaber has collaborated with scholars based in United States, Argentina and Denmark. Frequent co-authors include Terence C. Amis, Paula D. Strassle, Rafael Meza, Richard A. LeCouteur, Jennifer L. Lund, Francisco Schlottmann, Marco G. Patti, Mark M. Smith, Julie J. Ruterbusch and Michele L. Coté. Their work appears in journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026